The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 21, 2019
Filed:
Feb. 18, 2014
Applicant:
Apeiron Biologics Ag, Vienna, AT;
Inventors:
Hans Loibner, Vienna, AT;
Oliver Mutschlechner, Wiener Neudorf, AT;
Ruth Ladenstein, Vienna, AT;
Isabel Klier, Vienna, AT;
Assignee:
APEIRON BIOLOGICS AG, Vienna, AT;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/55 (2006.01); C07K 16/28 (2006.01); A61K 31/485 (2006.01); A61K 45/06 (2006.01); C07K 16/30 (2006.01); A61K 39/395 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/3084 (2013.01); A61K 31/485 (2013.01); A61K 39/39533 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); C07K 14/55 (2013.01); C07K 16/28 (2013.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); C07K 2317/24 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01); C07K 2317/76 (2013.01); C07K 2319/00 (2013.01);
Abstract
Preparations and methods for treating a GD2 positive cancer by administering a preparation comprising an anti-GD2 antibody to a patient, wherein the patient is not concomitantly treated with Interleukin-2 (IL-2), and wherein one or more treatment periods with the antibody may be preceded, accompanied, and/or followed by one or more treatment periods with a retinoid.